Management of Diphenhydramine Overdose with Hallucinations
For a patient experiencing hallucinations from diphenhydramine (Benadryl) overdose, physostigmine is the most effective antidote to reverse anticholinergic toxicity, though benzodiazepines should be used first-line for seizure control and agitation management.
Primary Treatment Approach
The hallucinations you're observing represent central anticholinergic syndrome from diphenhydramine overdose. This creates a critical clinical scenario requiring immediate intervention:
First-Line Management: Physostigmine
Physostigmine is the specific reversal agent for anticholinergic toxicity and has demonstrated effectiveness in reversing hallucinations, delirium, and other central nervous system manifestations of diphenhydramine overdose 1, 2.
- Dosing: 2 mg IV administered slowly, can be repeated every 20-30 minutes as needed
- Mechanism: Crosses blood-brain barrier to reverse central anticholinergic effects
- Expected response: Rapid improvement in mental status, resolution of hallucinations within minutes to hours 2
In one documented case, a patient with severe hallucinatory psychosis from 1.5g diphenhydramine overdose received four doses of 2 mg physostigmine IV with complete symptom resolution within 12 hours 2.
Concurrent Supportive Care
Benzodiazepines for agitation and seizures: If the patient is agitated or at risk for seizures, administer benzodiazepines alongside physostigmine 1, 2:
- Lorazepam 1-2 mg IV or diazepam 5 mg IV
- Can be repeated as needed for ongoing agitation
Sodium bicarbonate for cardiac toxicity: If QRS widening or ventricular dysrhythmias are present (sodium channel blockade), administer sodium bicarbonate 3, 4:
- 1-2 mEq/kg IV bolus
- Target arterial pH 7.45-7.55
Clinical Monitoring Requirements
Monitor continuously for:
- Cardiac: ECG for QRS widening, QTc prolongation, dysrhythmias (sinus tachycardia is expected)
- Neurologic: Seizure activity, level of consciousness, resolution of hallucinations
- Vital signs: Hyperthermia (can reach dangerous levels), tachycardia, hypertension
- Respiratory: Potential for respiratory depression, especially if benzodiazepines are used
Critical Pitfalls to Avoid
Do NOT use additional anticholinergic medications: Antipsychotics like haloperidol have anticholinergic properties and will worsen the toxidrome 5, 6. The evidence provided discusses antipsychotics for primary psychiatric agitation, not anticholinergic delirium—this is a completely different clinical scenario.
Recognize the anticholinergic toxidrome: Classic presentation includes:
- Hallucinations (visual and auditory)
- Hyperthermia
- Dry, flushed skin
- Mydriasis (dilated pupils)
- Urinary retention
- Decreased bowel sounds
- Tachycardia
- Altered mental status ranging from agitation to coma 2, 7
Avoid physostigmine if: Contraindications include cardiac conduction abnormalities, mechanical bowel obstruction, or asthma exacerbation. In these cases, rely on benzodiazepines and supportive care.
Expected Clinical Course
Most diphenhydramine overdoses have an uncomplicated course with appropriate treatment 7. Symptoms typically resolve within 12-24 hours with supportive care and physostigmine administration 2. However, severe cases can progress to:
- Status epilepticus
- Cardiac arrest
- Respiratory failure
- Extreme hyperthermia
- Coma
These complications require ICU-level care with advanced life support measures 1, 3.
Decontamination Considerations
If presentation is within 1-2 hours of ingestion:
- Activated charcoal 50g PO/NG (if airway protected)
- Gastric lavage only if massive ingestion and very recent (<1 hour)
Do not delay antidote administration for decontamination procedures if the patient is already symptomatic with hallucinations.
Disposition
All symptomatic diphenhydramine overdoses require hospital admission for monitoring. Patients with severe toxicity (seizures, cardiac dysrhythmias, coma) need ICU admission 1, 3. Given the suicidal intent in most cases 7, psychiatric evaluation is mandatory once medically stable.